Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin crossover study in adult males with X-linked adrenoleukodystrophy
NL-OMON22008Recruiting
- Sponsor
- Merck & Co.
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of lovastatin in adrenoleukodystrophy (ALD) (2 arms), sponsored by Merck & Co. Primary endpoints: Very long chain fatty acid levels in plasma and Very long chain fatty acid levels in erythrocytes. Started Aug 2006; status: recruiting.
02
Drugs
lovastatin
03
Conditions
adrenoleukodystrophy (ALD)
Beyond the preview
Go deeper on NL-OMON22008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22008.